Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E0ZS
|
||||
Former ID |
DNC011105
|
||||
Drug Name |
N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531085] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H18N2O
|
||||
Canonical SMILES |
CC(=O)NC1=CC=CC(=C1)C2=CC=C(C=C2)CC3=CC=NC=C3
|
||||
InChI |
1S/C20H18N2O/c1-15(23)22-20-4-2-3-19(14-20)18-7-5-16(6-8-18)13-17-9-11-21-12-10-17/h2-12,14H,13H2,1H3,(H,22,23)
|
||||
InChIKey |
HURKLDLRCGKBKL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [531085] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [531085] | ||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
SteroidogenesisPW000141:Steroidogenesis | |||||
WikiPathways | Metapathway biotransformation | ||||
Steroid Biosynthesis | |||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.